Quantum Genomics SA (ALQGC) — Financial Flexibility Index
Quantum Genomics SA (ALQGC) has a Financial Flexibility Index of -1.85x as of June 2023. Free cash flow of €-7.64 Million (operating CF €-7.64 Million minus capex €0.00) represents -2% of total liabilities (€4.13 Million). Check ALQGC capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Quantum Genomics SA Financial Flexibility Index (2012–2022)
Historical Financial Flexibility Index trend for Quantum Genomics SA across 11 annual periods. See Quantum Genomics SA (ALQGC) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Quantum Genomics SA (2012–2022)
Year-by-year free cash flow to debt coverage for Quantum Genomics SA. For the full company profile including market capitalisation, see ALQGC market cap.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2022 | -1.01x | €-20.18 Million | €-20.21 Million | €20.05 Million | ▲ +31.4% |
| 2021 | -1.47x | €-16.97 Million | €-17.02 Million | €11.57 Million | ▼ -3.2% |
| 2020 | -1.42x | €-11.58 Million | €-11.99 Million | €8.15 Million | ▲ +25.9% |
| 2019 | -1.92x | €-10.31 Million | €-10.43 Million | €5.37 Million | ▼ -16.6% |
| 2018 | -1.65x | €-10.88 Million | €-10.90 Million | €6.61 Million | ▼ -4.2% |
| 2017 | -1.58x | €-7.97 Million | €-7.98 Million | €5.05 Million | ▲ +21.5% |
| 2016 | -2.01x | €-5.46 Million | €-5.53 Million | €2.72 Million | ▼ -62.3% |
| 2015 | -1.24x | €-3.12 Million | €-3.14 Million | €2.52 Million | ▼ -118.7% |
| 2014 | -0.57x | €-2.77 Million | €-2.79 Million | €4.88 Million | ▼ -115.0% |
| 2013 | -0.26x | €-875.00K | €-987.00K | €3.32 Million | ▲ +5.9% |
| 2012 | -0.28x | €-553.00K | €-614.00K | €1.97 Million | — |